News | June 24, 2009

CorNova Receives CE Mark for Valecor Platinum Coronary Stent

June 24, 2009 – CorNova Inc. said this week it received CE mark approval for its Valecor Platinum Coronary Stent System, a next generation cobalt-chromium bare metal stent.

Utilizing a novel ion-based implantation technology called Nanofusion, the Valecor Platinum stent presents a pure platinum surface to both the lumen and artery wall to provide protection from less biocompatible components inherent in all medical-grade alloys. Platinum is known for its superior biocompatibility and biostability. In addition, the stent offers some of the thinnest struts available and a novel open cell design that maximizes flexibility and conformability, while causing minimal inflammation and tissue damage during deployment, the company said.

For more information: www.cornova.com

Related Content

FDA Approves New Indication for NuMed CP Stent System
Technology | Stents Bare Metal| December 14, 2017
The U.S. Food and Drug Administration (FDA) announced clearance for NuMed’s Cheatham Platinum (CP) Stent System, which...
Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Biotronik, PRO-Kinetic Energy cobalt chromium coronary stent system, FDA approval
Technology | Stents Bare Metal| February 15, 2017
The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U.S. Food and Drug...
Technology | Stents Bare Metal| December 09, 2015
Medinol U.S. recently opened their commercial business in Parsippany, New Jersey, followed by the launch of the...
Overlay Init